000 01566 a2200421 4500
005 20250518055033.0
264 0 _c20191009
008 201910s 0 0 fre d
022 _a1769-6917
024 7 _a10.1016/j.bulcan.2019.05.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCanlorbe, Geoffroy
245 0 0 _a[Should the results of the LACC trial modify French practices for the choice of surgical approach for the treatment of early-stage cervical cancer ? The point of view of the CNGOF Cancer Commission].
_h[electronic resource]
260 _bBulletin du cancer
_cOct 2019
300 _a843-846 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAdenocarcinoma
_xmortality
650 0 4 _aCarcinoma, Adenosquamous
_xmortality
650 0 4 _aCarcinoma, Squamous Cell
_xmortality
650 0 4 _aEquivalence Trials as Topic
650 0 4 _aFemale
650 0 4 _aFrance
650 0 4 _aHumans
650 0 4 _aHysterectomy
_xmethods
650 0 4 _aLaparoscopy
650 0 4 _aLaparotomy
_xmortality
650 0 4 _aLearning Curve
650 0 4 _aMulticenter Studies as Topic
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRobotic Surgical Procedures
650 0 4 _aTreatment Outcome
650 0 4 _aUterine Cervical Neoplasms
_xmortality
700 1 _aLevêque, Jean
700 1 _aKoskas, Martin
773 0 _tBulletin du cancer
_gvol. 106
_gno. 10
_gp. 843-846
856 4 0 _uhttps://doi.org/10.1016/j.bulcan.2019.05.006
_zAvailable from publisher's website
999 _c30037873
_d30037873